Target intelligence / Profile preview

Antigen-uptake receptors on antigen-presenting cells

Molecular classification
Receptor, Other
01

Overview

Antigen-uptake receptors on antigen-presenting cells (APCs), such as dendritic cells and macrophages, are a diverse group of surface proteins that mediate the entry of vaccine components into the immune system. In the context of the Pediacel vaccine, these receptors recognize and internalize various antigens—including diphtheria, tetanus, and pertussis toxoids—often complexed with aluminum phosphate adjuvants (Kool et al., 2008, Nature Medicine). Key receptors involved in this process include C-type lectin receptors (CLRs) like the Mannose Receptor (CD206) and DEC-205, which facilitate the transport of antigens into endosomal compartments for processing (Ghazarian et al., 2011, Current Opinion in Chemical Biology). The aluminum adjuvant enhances this process by promoting the recruitment of APCs to the injection site and facilitating the uptake of antigen-adjuvant complexes through macropinocytosis or phagocytosis (Ghimire et al., 2017, Frontiers in Immunology). Once internalized, the aluminum component can activate the NLRP3 inflammasome, while the protein antigens are proteolytically degraded and presented on MHC molecules to initiate a protective adaptive immune response (Marrack et al., 2009, Nature Reviews Immunology). These receptors are essential for the efficacy of multi-component vaccines like Pediacel, as they bridge the gap between innate recognition and long-term immunological memory.

Other names
Endocytic receptorsPattern recognition receptorsC-type lectin receptorsScavenger receptorsAPC uptake receptorsAntigen-uptake receptors on antigen-presenting cells recognizing Pediacel antigens and aluminum-adsorbed antigen complexes
02

Mechanism of action

Internalization of vaccine antigens and adjuvants via receptor-mediated endocytosis or phagocytosis, followed by proteolytic processing and MHC-mediated antigen presentation to T cells.

03

Biological functions

Immune responseAntigen processing and presentationEndocytosisPhagocytosis
04

Disease associations

Infection
05

Safety considerations

Injection site reactionsGranuloma formationHypersensitivity to aluminumMacrophagic myofasciitis
06

Interacting drugs

Pediacel

6 more in the full profile.

07

Biomarkers

CD80CD86MHC class IIIL-1 betaCD40

Beyond the preview

Go deeper on Antigen-uptake receptors on antigen-presenting cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-uptake receptors on antigen-presenting cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call